ArticleJournal of experimental & clinical cancer research : CR2023

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma.

Lidia Giraudo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.